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Purpose/Objective: To implement a time effective solution 
to enable radiotherapy centres across the UK to remotely 
access and register a database of CT/CBCT images. The 
purpose was to facilitate the IGRT training and assessment of 
RTTs throughout the UK in order to provide QA for those 
clinical trials requiring IGRT. 
Materials and Methods: The process was initially 
implemented for the HYpofractionated Bladder Radiotherapy 
with or without Image guided aDaptive planning (HYBRID) 
Trial (CRUK/12/055), requiring CBCT analysis for plan of the 
day selection. The anonymised treatment datasets from 5 
patients, each containing 6 CT/CBCT images registered to the 
acquisition position, were imported into two vendor systems. 
Three patient cases (18 CBCT images) and the consensus plan 
of the day selection, consistent with the HYBRID Trial RT 
guidelines, were provided for training. 2 patient cases (12 
CBCT images) were provided for assessment. Detailed 
instructions and support were provided for participating 
centres in remotely accessing their vendor appropriate 
database.  
Individual centres were asked to complete an internet survey 
to obtain feedback on the process regarding image quality, 
usability, and general experience. 
Results: Remote training has been accessed by 10 
Radiotherapy centres across the UK recruiting patients into 
the HYBRID Trial. One centre completed the training as a 
group, while others accessed individually. The assessment 
required individuals to perform a bladder registration of CT 
and CBCT, and select the correct treatment plan from a 
library of 3 plans. This has been completed by 67 Individuals. 
54 individuals successfully completed the assessment cases 
with a pass mark of 83% (10/12 cases) or above on a first 
attempt; the remaining 13 achieved the pass mark on a 
second attempt following verbal feedback on the QA process. 
A pre-requisite of the adaptive trial was that centres had 
previous experience in CBCT soft tissue analysis for bladder 
cancer. The majority of centres (70%) reported individuals 
taking less than 1 hour to complete the training cases and 
86% of the respondents reported that the image quality 
across the systems was sufficient for them to effectively 
carry out the assessment. 
All centres responded that the training and assessment cases 
provided were sufficient to familiarise them with the trial 
protocol, and that the training and assessment had prepared 
them for plan selection within the trial. 
Conclusions: It is feasible and practical to use remote 
systems to train and assess IGRT competency for multi-centre 
clinical trials. This solution will be extended to UK clinical 
trials involving IGRT for other anatomical sites.  
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Purpose/Objective: In case of prostatic irradiation, dose 
constraints are designed for the whole rectum. A rectal sub-
region (RSR) may be especially involved in the risk of toxicity 
and may be highly predictive of toxicity. The goal of this 
work was to characterize this RSR. 
Materials and Methods: A total of 118 patients (pts) having 
received a total dose of 80Gy in prostate by IMRT with IGRT 
were included in this study. Rectal bleeding (RB) at three 
years was analyzed (≥ grade 1). A total of 31pts suffered from 
RB. Following a leave-one-out cross validation scheme, each 
patient was chosen as anatomical template of reference 
(ATR) towards which the anatomies of the 117 remaining 
patients were non-rigidly registered. The planned dose 
distributions of each patient were then propagated into the 
space of the ATR. A voxel-wise comparison (Mann-Whitney) 
was performed between the registered dose distributions of 
the two groups of pts (i.e. pts with or without RB). This 
enabled the segmentation of a RSR where the difference of 
dose between the two groups was significant (p<0.05). This 
RSR was then spatially characterized and its predictive 
performances were quantified by the area under the curve 
(AUC) resulting from logistic regression at each bin of its 
DVH.  
Results: The average volume of the identified RSRs was 
2.8cm3 (3.4% of the absolute rectal volume). The RSRs were 
mostly located in the anterior rectal wall (90% of the volume 
located at less than 16mm from the prostate) and in the 
inferior part of the rectum. In these RSRs, pts with RB 
received in average 3.8Gy more than the pts without RB. The 
AUC in the RSR was 71% whereas the AUC was 63% at the 
maximum in the other evaluated full rectum or rectal sub-
regions (anterior rectal wall only…).  
 
Conclusions: The identified RSR, likely involved in the risk of 
toxicity, is located in the anterior rectal wall, in the inferior 
part of the rectum. The RSR could be subject to specific dose 
constraints at the inverse planning step of IMRT to reduce the 
risk of toxicity, and be used to predict the risk of rectal 
bleeding. 
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Purpose/Objective: A general principle in patient radiation 
protection is to give the smallest effective dose in diagnostic 
or in therapy procedures. Patients benefiting from Breast 
Conservative Treatment (BCT) will all require adjuvant 
radiotherapy. This radiotherapy is usually performed with 
external beam radiation but can be, in selected cases, also 
delivered intra-operatively in a single session. The purpose of 
